CV Therapeutics

URI: https://gptkb.org/entity/CV_Therapeutics

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:acquiredBy	gptkb:Gilead_Sciences
gptkbp:acquisitionYear	2009
gptkbp:country	gptkb:United_States
gptkbp:focus	cardiovascular drugs
gptkbp:foundedYear	1992
gptkbp:founder	gptkb:Luis_Belardinelli
gptkbp:headquartersLocation	gptkb:Palo_Alto,_California,_United_States
gptkbp:industry	gptkb:biotechnology
gptkbp:notableProduct	gptkb:Lexiscan gptkb:Ranolazine
gptkbp:stockExchange	gptkb:NASDAQ
gptkbp:stockSymbol	gptkb:CVTX
gptkbp:bfsParent	gptkb:Gilead_Sciences
gptkbp:bfsLayer	5
https://www.w3.org/2000/01/rdf-schema#label	CV Therapeutics